Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
42,931,597
Value
$2.41B
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,931,597$2.41B0.1%−640,036−1.5%ReducedHolders
Q1 202643,571,633$2.09B0.1%−11,702,436−21.2%ReducedHolders
Q4 202555,274,069$2.14B0.1%+11,110,115+25.2%AddedHolders
Q3 202544,163,954$1.56B0.1%−2,440,149−5.2%ReducedHolders
Q2 202546,604,103$1.68B0.1%+5,574,271+13.6%AddedHolders
Q1 202541,029,832$1.28B0.1%+1,497,062+3.8%AddedHolders
Q4 202439,532,770$1.01B0.1%−1,545,393−3.8%ReducedHolders
Q3 202441,078,163$1.16B0.1%−3,055,283−6.9%ReducedHolders
Q2 202444,133,446$1.16B0.1%−84,439−0.2%ReducedHolders
Q1 202444,217,885$1.34B0.1%−2,136,381−4.6%ReducedHolders
Q4 202346,354,266$1.30B0.1%−1,778,349−3.7%ReducedHolders
Q3 202348,132,615$1.31B0.1%+702,754+1.5%AddedHolders
Q2 202347,429,861$1.46B0.1%+79,403+0.2%AddedHolders
Q1 202347,350,458$1.71B0.2%−1,895,574−3.8%ReducedHolders
Q4 202249,246,032$1.95B0.2%−940,129−1.9%ReducedHolders
Q3 202250,186,161$2.02B0.3%−1,357,010−2.6%ReducedHolders
Q2 202251,543,171$2.17B0.3%−1,998,617−3.7%ReducedHolders
Q1 202253,541,788$2.09B0.3%−2,688,902−4.8%ReducedHolders
Q4 202156,230,690$2.24B0.3%−1,074,621−1.9%ReducedHolders
Q3 202157,305,311$2.07B0.3%+6,511,270+12.8%AddedHolders
Q2 202150,794,041$2.08B0.3%+2,675,799+5.6%AddedHolders
Q1 202148,118,242$2.10B0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.